Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Researchers from Memorial Sloan Kettering Cancer Center describe findings in cancer vaccines
November 11th, 2008
Current study results from the report, 'Peptide vaccines for myeloid leukaemias,' have been published. "The development of cancer vaccines directed against myeloid leukaemias has been a research area of intense interest in the past decade. Both human studies in vitro and mouse models in vivo have demonstrated that leukaemia-associated antigens (LAAs), such as the fusion protein BCR-ABL, Wilms' tumor protein and proteinase 3, may serve as effective targets for cellular immunotherapy," scientists writing in the journal Bailliere's Best Practice and Research In Clinical Haematology report. "Peptide-based vaccines are able to induce cytotoxic T-lymphocyte responses...
Source: Cancer Weekly (2008-11-11)
|
